Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »

For full access to this article login to GEN Select now.

May 01, 2014 (Vol. 34, No. 9)

Plavix Lawsuits Target Personalized Medicine

States Sue BMS and Sanofi Over Drug’s Effects on Subpopulations

  • Drug developers have long trumpeted the potential of personalized medicine to revolutionize disease treatment by targeting new drugs to patients most likely to benefit. Now, the tangle of lawsuits nationwide over Plavix (clopidrogel) threatens to turn personalized medicine into a weapon against the biopharma industry. In addition to ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.